Cite
Padda J, Khalid K, Zubair U, et al. Chimeric Antigen Receptor T Cell Therapy and Its Significance in Multiple Myeloma. Cureus. 2021;13(6):e15917doi: 10.7759/cureus.15917.
Padda, J., Khalid, K., Zubair, U., Peethala, M. M., Kakani, V., Goriparthi, L., Almanie, A. H., Cooper, A. C., & Jean-Charles, G. (2021). Chimeric Antigen Receptor T Cell Therapy and Its Significance in Multiple Myeloma. Cureus, 13(6), e15917. https://doi.org/10.7759/cureus.15917
Padda, Jaskamal, et al. "Chimeric Antigen Receptor T Cell Therapy and Its Significance in Multiple Myeloma." Cureus vol. 13,6 (2021): e15917. doi: https://doi.org/10.7759/cureus.15917
Padda J, Khalid K, Zubair U, Peethala MM, Kakani V, Goriparthi L, Almanie AH, Cooper AC, Jean-Charles G. Chimeric Antigen Receptor T Cell Therapy and Its Significance in Multiple Myeloma. Cureus. 2021 Jun 25;13(6):e15917. doi: 10.7759/cureus.15917. eCollection 2021 Jun. PMID: 34322356; PMCID: PMC8310625.
Copy
Download .nbib